H-1B sponsorship profile: Constellation Pharmaceuticals, Inc. Across U.S. Department of Labor LCA disclosures, Constellation Pharmaceuticals, Inc filed 8 Labor Condition Applications covering 8 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (8 certified of 8 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Constellation Pharmaceuticals, Inc’s H-1B petitions range from $137,000 at the low end to $185,000 at the high end, with a petition-weighted average of $169,498. That range reflects the mix of occupations the company sponsors, led by Assoc Dir., Drug Product Development & Technical Operations (3 petitions at $174,000 avg), followed by Associate Director, CMC Analytical Development & QC and Sr Scientist I, CMC Ops and Planning. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Constellation Pharmaceuticals, Inc is headquartered in Boston, MA under NAICS code 541714, and places H-1B workers across 4 states, most heavily in MA, OH, WA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Constellation Pharmaceuticals, Inc ranks. By H-1B petition volume, Constellation Pharmaceuticals, Inc is #19,368 of 119,880 employers nationally and #850 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.